141st APHA Annual Meeting

In This section

290699
An evaluation of how the patient protection and affordable care act advances the national quality strategy, national prevention strategy and healthy people goals to reduce disparities in care of people with disabilities

Sunday, November 3, 2013

Miranda Chung, MPH, DrPH(c) , School of Health Science & Practice, Department of Health Policy & Management, New York Medical College, Valhalla, NY
Deborah Viola, PhD , Department of Health Policy and Management, School of Health Sciences & Practice, Valhalla, NY
David O'Hara, PhD , Westchester Institute for Human Development, Valhalla, NY
Harvey Schwartz, PhD, MBA , Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services, Rockville, MD
As a result of the Patient Protection and Affordable Care Act (PPACA), the National Quality Strategy (NQS) was created with an emphasis on better quality care, healthy people, communities, and affordable care. The National Prevention Strategy (NPS) Framework, released in 2011, proposed a change in emphasis from sickness to wellness. The NPS focus on community environments, preventive services, empowered people, and the elimination of health disparities is supportive of Healthy People 2020 (HP2020) goals to achieve health equity and eliminate disparities for a more equitable society. The purpose of our study was to evaluate and reconcile the NQS, NPS Framework and HP2020 Goals to reduce disparities for the disabled. We assessed whether specific provisions of the PPACA have the potential to support initiatives outlined in the NQS, NPS and the HP2020 target of 10% improvement in prevention and reduction of chronic diseases for the disabled. High-risk pools for pre-existing conditions and insurance rescission bans should reduce disparities among the disabled. Patient-centered care, medical homes, and a reallocation of resources to home and community based services should improve the level of and coordination of services. Specific provisions intended for other vulnerable groups, e.g., women, minorities and older Americans, should also improve health care and outcomes for the disabled. However, the implementation of state level exchanges and budgetary decisions may have unintended consequences for lower-income groups. Overall, the PPACA supports the NQS, NPS and HP2020 goals, with increased attention on prevention and increased access to care for the disabled.

Learning Areas:
Advocacy for health and health education
Public health or related organizational policy, standards, or other guidelines
Public health or related public policy

Learning Objectives:
Demonstrate how the National Prevention Strategy and HP2020 thru the PPACA would reduce the proportion of people with disabilities who encounter barriers to participating in home, school, work or community activities; Assess how the NQS, NPS, HP2020 thru the PPACA would reduce the proportion of people with disabilities who report physical or program barriers to local health or wellness programs; Analyze how the NQS, NPS, HP2020 thru the PPACA would reduce the proportion of people with disabilities who report delays in receiving primary and periodic preventive care due to specific barriers.

Keywords: Disability, Access to Health Care

Presenting author's disclosure statement:
Organization/institution whose products or services will be discussed: NA

Qualified on the content I am responsible for because: With a Masters degree in public health(2010)concentrated on international health, I am a doctoral candidate at New York Medical College (Health Policy and Management). I am also mentored and supervised by Dr. Deborah Viola, PhD, Associate Professor and Associate Director of the Doctoral Program. My research interests include health disparities, the disabled population, the aging population, maternal and child health, health policy and cancer research.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.